AACS Gene - Acetoacetyl-CoA Synthetase

Comprehensive gene information for AACS, encoding acetoacetyl-CoA synthetase involved in ketone body metabolism and lipid biosynthesis.

Gene Information Card

Symbol AACS
Full Name Acetoacetyl-CoA Synthetase
Gene Type Protein-coding
Chromosomal Location 12q24.31
NCBI Gene ID 65985 ncbi.nlm.nih.gov/gene/65985
Ensembl ID ENSG00000111206
UniProt ID Q86V21
OMIM ID 614364
HGNC ID 21299
Aliases ACS, ACSF1, MGC138207

Description

The AACS gene encodes acetoacetyl-CoA synthetase, an enzyme that catalyzes the conversion of acetoacetate to acetoacetyl-CoA in the presence of ATP and CoA. This reaction is a key step in ketone body utilization and lipid biosynthesis, particularly in the brain and liver. The enzyme plays a role in cholesterol and fatty acid synthesis by providing acetoacetyl-CoA as a precursor.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency Potential involvement in ketone body metabolism disruption; AACS dysfunction may impair acetoacetyl-CoA production, affecting HMG-CoA synthesis. Inferred from metabolic pathway similarity; no direct ClinVar association.
Hypercholesterolemia AACS contributes to cholesterol biosynthesis; altered expression may influence lipid levels. Inferred from biochemical function; no direct disease association in OMIM.
Cancer (general) AACS expression changes observed in certain tumors; may support lipid synthesis for proliferation. COSMIC database reports somatic mutations in various cancers.

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Brain 8.3 Medium
Kidney 6.1 Low
Heart 4.2 Low
Skeletal Muscle 2.8 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.0 Hepatocellular carcinoma cell line; high expression
SH-SY5Y 9.5 Neuroblastoma cell line; moderate expression
HEK293 7.2 Embryonic kidney cells; moderate expression
A549 5.0 Lung carcinoma cell line; low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1015C>T (p.Arg339Trp) Missense <0.01% Unknown; predicted possibly damaging by in silico tools
c.1246G>A (p.Gly416Ser) Missense <0.01% Unknown; predicted benign
c.1573_1574del (p.Leu525fs) Frameshift <0.01% Likely loss of function; truncation
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations (e.g., p.Leu525fs) likely result in truncated, non-functional enzyme, impairing acetoacetyl-CoA synthesis.

Gain of Function (GOF)

No known gain-of-function mutations reported.

Dominant Negative (DN)

No evidence for dominant-negative effects.

Gene Ontology (GO)

• GO:0003988 - acetoacetyl-CoA synthetase activity • GO:0005524 - ATP binding
• GO:0006633 - fatty acid biosynthetic process • GO:0006695 - cholesterol biosynthetic process
• GO:0046951 - ketone body catabolic process

Pathways

Ketone body metabolism (Reactome: R-HSA-77111)
Cholesterol biosynthesis (Reactome: R-HSA-191273)
Fatty acid biosynthesis (KEGG: hsa00061)

Protein Summary

Acetoacetyl-CoA synthetase (UniProt Q86V21) is a 65 kDa cytosolic enzyme that catalyzes the ligation of acetoacetate with CoA to form acetoacetyl-CoA. It is highly expressed in liver and brain, where it supports ketone body utilization and lipid synthesis. The protein contains an ATP-binding domain and a CoA-binding site, essential for its catalytic activity.

Related Products

Product name Cat.No. Species Gene ID
AACS Knockout HEK293 Cell Line EDJ-KQ3950 Human 65985 Details Get a Quote
AACS Knockout A-549 Cell Line EDJ-KQ26211 Human 65985 Details Get a Quote
AACS Knockout HCT 116 Cell Line EDJ-KQ26212 Human 65985 Details Get a Quote
AACS Knockout HeLa Cell Line EDJ-KQ24869 Human 65985 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: